Precision Medicine Collaboration to Increase Options for Cancer Patients
Baylor Research Institute and the Translational Genomics Research Institute (TGen) in Phoenix, AZ, announced an agreement that will focus on accelerating early detection and treatments for patients with a broad range of cancers. This collaboration will impact cancer patients in North Texas and beyond by offering even more novel therapies like liquid biopsies, gene sequencing, personalized vaccines and one-of-a-kind clinical trials